BioSpace News Archive

Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST and TSX-V: ACST), today announced that it will host a conference call at 1:00 PM Eastern Time on Tuesday, June 21, 2022, to discuss the Company’s corporate progress and other developments, as well as financial results for fiscal year 2022 ended March 31, 2022.

Myovant Sciences announced that it approved equity awards for 23 new employees with a grant date of June 15, 2022 pursuant to Myovant’s 2020 Inducement Plan.

Geron Corporation reported that it has granted a non-statutory stock option to purchase an aggregate of 70,000 shares of Geron common stock as an inducement to a newly hired employee in connection with commencement of employment with the Company.

Rapid Dose Therapeutics Corp. announces that it will not be in a position to file its audited annual financial statements for the fiscal year ended February 28, 2022, including the related management’s discussion and analysis and CEO and CFO certifications by the filing deadline of June 28, 2022.